These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33233644)

  • 1. Genetic Background Underlying 5-HT
    Kondaurova EM; Rodnyy AY; Ilchibaeva TV; Tsybko AS; Eremin DV; Antonov YV; Popova NK; Naumenko VS
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in pharmacological and behavioural responses in recombinant mouse line with an increased predisposition to catalepsy: role of the 5-HT1A receptor.
    Kulikova EA; Bazovkina DV; Akulov AE; Tsybko AS; Fursenko DV; Kulikov AV; Naumenko VS; Ponimaskin E; Kondaurova EM
    Br J Pharmacol; 2016 Jul; 173(13):2147-61. PubMed ID: 27004983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Central Administration of Brain-Derived Neurotrophic Factor (BDNF) on Behavior and Brain Monoamine Metabolism in New Recombinant Mouse Lines Differing by 5-HT
    Bazovkina D; Naumenko V; Bazhenova E; Kondaurova E
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat.
    Riad M; Zimmer L; Rbah L; Watkins KC; Hamon M; Descarries L
    J Neurosci; 2004 Jun; 24(23):5420-6. PubMed ID: 15190115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monamine synthesis in the rat brain in vivo.
    Esteban S; Lladó J; Sastre-Coll A; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):135-43. PubMed ID: 10494882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrogated Freud-1/Cc2d1a Repression of 5-HT1A Autoreceptors Induces Fluoxetine-Resistant Anxiety/Depression-Like Behavior.
    Vahid-Ansari F; Daigle M; Manzini MC; Tanaka KF; Hen R; Geddes SD; Béïque JC; James J; Merali Z; Albert PR
    J Neurosci; 2017 Dec; 37(49):11967-11978. PubMed ID: 29101244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Adult 5-HT1A Autoreceptors Results in a Paradoxical Anxiogenic Response to Antidepressant Treatment.
    Turcotte-Cardin V; Vahid-Ansari F; Luckhart C; Daigle M; Geddes SD; Tanaka KF; Hen R; James J; Merali Z; Béïque JC; Albert PR
    J Neurosci; 2019 Feb; 39(8):1334-1346. PubMed ID: 30552180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect of C1473G polymorphism in the tryptophan hydroxylase 2 gene on the response of the brain serotonin system to chronic fluoxetine treatment in mice.
    Bazhenova EY; Sinyakova NA; Kulikova EA; Kazarinova IA; Bazovkina DV; Gainetdinov RR; Kulikov AV
    Neurosci Lett; 2017 Jul; 653():264-268. PubMed ID: 28579486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid receptor antagonism augments fluoxetine-induced downregulation of the 5-HT transporter.
    Johnson DA; Ingram CD; Grant EJ; Craighead M; Gartside SE
    Neuropsychopharmacology; 2009 Jan; 34(2):399-409. PubMed ID: 18496518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key role of the 5-HT1A receptor addressing protein Yif1B in serotonin neurotransmission and SSRI treatment.
    Martin V; Mathieu L; Diaz J; Salman H; Alterio J; Chevarin C; Lanfumey L; Hamon M; Austin MC; Darmon M; Stockmeier CA; Masson J
    J Psychiatry Neurosci; 2020 Sep; 45(5):344-355. PubMed ID: 32459080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol accelerates the effects of fluoxetine on serotonin 1A receptor signaling.
    Li Q; Sullivan NR; McAllister CE; Van de Kar LD; Muma NA
    Psychoneuroendocrinology; 2013 Jul; 38(7):1145-57. PubMed ID: 23219224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA; Nguyen HQ; Smith DL; Schechter LE
    J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects.
    Bortolozzi A; Castañé A; Semakova J; Santana N; Alvarado G; Cortés R; Ferrés-Coy A; Fernández G; Carmona MC; Toth M; Perales JC; Montefeltro A; Artigas F
    Mol Psychiatry; 2012 Jun; 17(6):612-23. PubMed ID: 21808255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.
    Moser PC; Sanger DJ
    Eur J Pharmacol; 1999 May; 372(2):127-34. PubMed ID: 10395092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
    Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
    Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM; Monge A; Del Río J; Lasheras B
    Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the 5-HT1A serotonin receptor in the hippocampus is required for social stress resilience and the antidepressant-like effects induced by the nicotinic partial agonist cytisine.
    Mineur YS; Einstein EB; Bentham MP; Wigestrand MB; Blakeman S; Newbold SA; Picciotto MR
    Neuropsychopharmacology; 2015 Mar; 40(4):938-46. PubMed ID: 25288485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality.
    Castro E; Díaz A; Rodriguez-Gaztelumendi A; Del Olmo E; Pazos A
    Neuropharmacology; 2008 Dec; 55(8):1391-6. PubMed ID: 18809415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.